跳至主要内容
临床试验/EUCTR2020-004167-29-BE
EUCTR2020-004167-29-BE进行中(未招募)1 期

Study of the noninferiority of an oral versus intravenous administration of tranexamic acid in total hip arthroplasty

CHU de Liège0 个研究点目标入组 258 人开始时间: 2021年2月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
258

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Adult patients >18 year old
  • - Physical status score ASA 1-2-3
  • - Scheduled for total hip arthroplasty, under regional anesthesia (supra-inguinal fascia-iliaca block) combined with general or spinal anesthesia.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 129
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 129

排除标准

  • Kidney injury
  • Pregnant women
  • Patients who were diagnosed with thromboembolic disease in last 12 months
  • Patients having undergone a digestive surgery that could lead to malabsorption (sleeve, by-pass, gastrectomy, intragastric balloon)
  • Insulin-dependent diabetic with gastroparesis

研究者

发起方
CHU de Liège

相似试验